Chronic rhinitis (CR) presents with symptoms such as rhinorrhea, nasal congestion, itching, and sneezing. Epidemiological surveys indicate that roughly 10–40 % of the population experiences the condition, making it a common disorder.
CR is categorized according to the presence of a specific IgE response to causative allergens: allergic rhinitis (AR) when IgE‑mediated, and non‑allergic rhinitis (NAR) when such a response is absent.
The principal pharmacologic agents employed for both AR and NAR include antihistamines, intranasal corticosteroids, nasal decongestants, and leukotriene‑receptor antagonists.
調査・レポート2026年9月5日•1分で読めます
Chronic Rhinitis: Prevalence, Classification, and Standard Therapies
Chronic rhinitis affects 10‑40% of people and is divided into allergic and non‑allergic types; treatment typically involves antihistamines, nasal steroids, decongestants, and leukotriene antagonists.
PharmaCountryチームがまとめました · 出典: KPA News
トピック:#chronic rhinitis#allergic rhinitis#nonallergic rhinitis#antihistamines#nasal steroids#leukotriene antagonists
評価
(0)
(0)
(0)
(0)
(0)
評価を残す